# Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

> **NCT05665504** · — · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 250 (estimated)

## Conditions studied

- Lung; Node
- Adenocarcinoma of Lung

## Interventions

- **DIAGNOSTIC_TEST:** DetermaRX

## Key facts

- **NCT ID:** NCT05665504
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-11
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05665504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05665504, "Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05665504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*